SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-272900
Filing Date
2020-10-20
Accepted
2020-10-20 16:36:02
Documents
3
Period of Report
2020-10-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d11649d8k.htm 8-K 23573
2 EX-3.1 d11649dex31.htm EX-3.1 34578
3 EX-3.2 d11649dex32.htm EX-3.2 159835
  Complete submission text file 0001193125-20-272900.txt   219134
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39614 | Film No.: 201248646
SIC: 2836 Biological Products, (No Diagnostic Substances)